Discounted Cash Flow (DCF) Analysis Levered
TELA Bio, Inc. (TELA)
$11.78
-0.29 (-2.40%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 4.25 | 8.27 | 15.45 | 18.21 | 29.46 | 48.71 | 80.52 | 133.12 | 220.07 | 363.82 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | -16.37 | -19.92 | -25.52 | -24.46 | -30.43 | -100.26 | -165.75 | -274.01 | -453 | -748.89 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -0.11 | -1.56 | -2.70 | -0.17 | -0.63 | -4.10 | -6.78 | -11.20 | -18.52 | -30.61 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | -16.48 | -21.49 | -28.22 | -24.62 | -31.06 | -104.36 | -172.52 | -285.21 | -471.51 | -779.50 |
Weighted Average Cost Of Capital
Share price | $ 11.78 |
---|---|
Beta | 0.985 |
Diluted Shares Outstanding | 12.93 |
Cost of Debt | |
Tax Rate | 0.00 |
After-tax Cost of Debt | -11.42% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.166 |
Total Debt | 31.49 |
Total Equity | 152.37 |
Total Capital | 183.86 |
Debt Weighting | 17.13 |
Equity Weighting | 82.87 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 4.25 | 8.27 | 15.45 | 18.21 | 29.46 | 48.71 | 80.52 | 133.12 | 220.07 | 363.82 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | -16.37 | -19.92 | -25.52 | -24.46 | -30.43 | -100.26 | -165.75 | -274.01 | -453 | -748.89 |
Capital Expenditure | -0.11 | -1.56 | -2.70 | -0.17 | -0.63 | -4.10 | -6.78 | -11.20 | -18.52 | -30.61 |
Free Cash Flow | -16.48 | -21.49 | -28.22 | -24.62 | -31.06 | -104.36 | -172.52 | -285.21 | -471.51 | -779.50 |
WACC | ||||||||||
PV LFCF | -99.57 | -157.05 | -247.72 | -390.74 | -616.31 | |||||
SUM PV LFCF | -1,511.39 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 4.81 |
Free cash flow (t + 1) | -795.09 |
Terminal Value | -28,295.03 |
Present Value of Terminal Value | -22,371.57 |
Intrinsic Value
Enterprise Value | -23,882.97 |
---|---|
Net Debt | -12.44 |
Equity Value | -23,870.53 |
Shares Outstanding | 12.93 |
Equity Value Per Share | -1,845.50 |